Home > Insider Trading > Filing (0001144204-19-043047)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1137883	Brainstorm Cell Therapeutics Inc.	BCLI	Biological Products, (No Disgnostic Substances) (2836)	207273918

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1245607	Irit Arbel	C/O Brainstorm Cell Therapeutics Inc. 1325 Avenue Of Americas, 28Th Floor New York NY 10019		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-08-28	6,666	$2.25	162,499	No	4	M	Direct
Common Stock	Acquisiton	2019-08-28	6,666	$2.25	169,165	No	4	M	Direct
Common Stock	Disposition	2019-08-28	13,332	$3.67	155,833	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-08-28	6,666	$0.00	6,666	$2.25
Common Stock	Stock Option (right to buy)	Disposition	2019-08-28	6,666	$0.00	6,666	$2.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-12-13	2019-12-13	No	4	M	Direct
0	2010-08-31	2019-08-31	No	4	M	Direct

Footnotes

This is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested and became exercisable as to 33.3% of the number of shares subject to the option on each of August 31, 2010, August 31, 2011 and August 31, 2012.